A multicenter, double-blind, phase 3B study to compare the safety and clinical efficacy of levofloxacin in 750mg for 2 weeks and levofloxacin 750mg for 3 weeks to that of levofloxacin 500mg for 4 weeks in the treatment of chronic prostatitis.

Trial Profile

A multicenter, double-blind, phase 3B study to compare the safety and clinical efficacy of levofloxacin in 750mg for 2 weeks and levofloxacin 750mg for 3 weeks to that of levofloxacin 500mg for 4 weeks in the treatment of chronic prostatitis.

Completed
Phase of Trial: Phase III

Latest Information Update: 12 Sep 2013

At a glance

  • Drugs Levofloxacin (Primary)
  • Indications Bacterial infections; Prostatitis
  • Focus Therapeutic Use
  • Sponsors Janssen Research & Development
  • Most Recent Events

    • 15 Apr 2010 Results published in Current Medical Research and Opinion.
    • 23 Nov 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 28 Oct 2008 Preliminary results were published in the proceedings of the 48th Interscience Conference on Antimicrobial Agents and Chemotherapy and 46th Annual Meeting of the Infectious Diseases Society of America - A Joint Meeting, 25 Oct 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top